Lab Information

Dr. Waqqas Afif

Clinical Research Unit
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 20%
 Epidemiology: 80%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Inflammatory bowel disease • Crohn's disease • ulcerative colitis • biologic medications • therapeutic drug monitoring

Research Interests

My research focuses on the safety and efficiency of biologic medications in the treatment of IBD. I am interested in the use of therapeutic drug monitoring to optimize the treatment of IBD patients on biologic medications.

Team Members

Name Position
Germain, Pascale Research Assistant
Recinto, Sherlaine Junior Assistant
Garceau, Esther Research Nurse
Laneuville, Jennifer Research Nurse
Lemieux, Carolyne Research Nurse
Ouellette-Cabana, Myriam Research Nurse

Latest Publications

  1. Khanna, R., Wilson, A. S., Gregor, J. C., Prowse, K. L. & Afif, W. (2021). Clinical Guidelines for the Management of IBD. Gastroenterology.
  2. Afif, W., Sattin, B., Dajnowiec, D., Khanna, R., Seow, C. H., Williamson, M., Karra, K., Wang, Y., Gao, L.-L. & Bressler, B. (2021). Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial. Digestive diseases and sciences.
  3. Cheifetz, A. S., Abreu, M. T., Afif, W., Cross, R. K., Dubinsky, M. C., Loftus, E. V., Osterman, M. T., Saroufim, A., Siegel, C. A., Yarur, A. J., Melmed, G. Y. & Papamichael, K. (2021). A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. The American journal of gastroenterology, vol. 116, p. 2014-2025.
  4. Golovics, P. A., Gonczi, L., Reinglas, J., Verdon, C., Pundir, S., Afif, W., Wild, G., Bitton, A., Bessissow, T. & Lakatos, P. L. (2021). Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study. Digestive diseases and sciences.
  5. Weizman, A. V., Bressler, B., Seow, C. H., Afif, W., Afzal, N. M., Targownik, L., Nguyen, D. M., Jones, J. L., Huang, V., Murthy, S. K. & Nguyen, G. C. (2021). Providing Hospitalized Ulcerative Colitis Patients With Practice Guidelines Improves Patient-Reported Outcomes. Journal of the Canadian Association of Gastroenterology, vol. 4, p. 131-136.
  6. Al Khoury, A., Balram, B., Bessissow, T., Afif, W., Gonczi, L., Abreu, M. & Lakatos, P. L. (2021). Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Digestive diseases and sciences.
  7. Verdon, C., Vande Casteele, N., Heron, V., Germain, P. & Afif, W. (2021). Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn's Disease. Journal of the Canadian Association of Gastroenterology, vol. 4, p. 73-77.
  8. Restellini, S. & Afif, W. (2021). Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease. Journal of clinical medicine, vol. 10.
  9. Benmassaoud, A., Bessissow, T., Wong, P., Fallone, C. A., Barkun, A., Afif, W., Forbes, N., Martel, M., Geraci, O. & Chen, Y.-I. (2021). Novel Negative Pressure Protective Box in Upper Digestive Endoscopy: A Prospective Case Series. The American journal of gastroenterology, vol. 116, p. 1339-1341.
  10. Al Khoury, A., Xiao, Y., Golovics, P. A., Kohen, R., Afif, W., Wild, G., Friedman, G., Galiatsatos, P., Hilzenrat, N., Szilagyi, A., Wyse, J., Cohen, A., Bitton, A., Bessissow, T. & Lakatos, P. L. (2021). Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 53, p. 980-986.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile